162 related articles for article (PubMed ID: 23983972)
1. The knowledge and attitudes of psychiatrists towards antipsychotic long-acting injections in Nigeria.
James BO; Omoaregba JO; Okonoda KM; Otefe EU; Patel MX
Ther Adv Psychopharmacol; 2012 Oct; 2(5):169-77. PubMed ID: 23983972
[TBL] [Abstract][Full Text] [Related]
2. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
[TBL] [Abstract][Full Text] [Related]
3. A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections.
Das AK; Malik A; Haddad PM
Ther Adv Psychopharmacol; 2014 Oct; 4(5):179-85. PubMed ID: 25360242
[TBL] [Abstract][Full Text] [Related]
4. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives.
Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
Can J Psychiatry; 2013 May; 58(5 Suppl 1):14S-22S. PubMed ID: 23945063
[TBL] [Abstract][Full Text] [Related]
5. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.
Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
Can J Psychiatry; 2013 May; 58(5 Suppl 1):23S-9S. PubMed ID: 23945064
[TBL] [Abstract][Full Text] [Related]
6. Clinical guideline recommendations for antipsychotic long-acting injections.
Kane JM; Garcia-Ribera C
Br J Psychiatry Suppl; 2009 Nov; 52():S63-7. PubMed ID: 19880920
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.
Verdoux H; Pambrun E; Tournier M; Bezin J; Pariente A
Schizophr Res; 2016 Dec; 178(1-3):58-63. PubMed ID: 27624680
[TBL] [Abstract][Full Text] [Related]
8. Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review.
Waddell L; Taylor M
Br J Psychiatry Suppl; 2009 Nov; 52():S43-50. PubMed ID: 19880916
[TBL] [Abstract][Full Text] [Related]
9. Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan.
Sugawara N; Kudo S; Ishioka M; Sato Y; Kubo K; Yasui-Furukori N
Neuropsychiatr Dis Treat; 2019; 15():205-211. PubMed ID: 30666117
[TBL] [Abstract][Full Text] [Related]
10. The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
Correll CU; Citrome L; Haddad PM; Lauriello J; Olfson M; Calloway SM; Kane JM
J Clin Psychiatry; 2016; 77(suppl 3):1-24. PubMed ID: 27732772
[TBL] [Abstract][Full Text] [Related]
11. Attitudes of European physicians towards the use of long-acting injectable antipsychotics.
Patel MX; Bent-Ennakhil N; Sapin C; di Nicola S; Loze JY; Nylander AG; Heres S
BMC Psychiatry; 2020 Mar; 20(1):123. PubMed ID: 32169077
[TBL] [Abstract][Full Text] [Related]
12. Discrepancy in Taiwanese psychiatrists' preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey.
Liu CH; Tsai PH; Chen CY
Neuropsychiatr Dis Treat; 2018; 14():429-433. PubMed ID: 29440904
[TBL] [Abstract][Full Text] [Related]
13. Attitude and perceptions of patients towards long acting depot injections (LAIs).
Grover S; Sahoo S; Bn S; Malhotra N; Dua D; Avasthi A
Asian J Psychiatr; 2019 Aug; 44():200-208. PubMed ID: 31419737
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.
Gundugurti PR; Nagpal R; Sheth A; Narang P; Gawande S; Singh V
Asian J Psychiatr; 2017 Dec; 30():88-93. PubMed ID: 28843143
[TBL] [Abstract][Full Text] [Related]
15. Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study.
Verdoux H; Pambrun E; Tournier M; Bezin J; Pariente A
Acta Psychiatr Scand; 2017 May; 135(5):429-438. PubMed ID: 28332704
[TBL] [Abstract][Full Text] [Related]
16. First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies.
Haddad PM; Taylor M; Niaz OS
Br J Psychiatry Suppl; 2009 Nov; 52():S20-8. PubMed ID: 19880913
[TBL] [Abstract][Full Text] [Related]
17. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
[TBL] [Abstract][Full Text] [Related]
18. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
Patel MX; Nikolaou V; David AS
Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
[TBL] [Abstract][Full Text] [Related]
19. Long-acting injectable antipsychotics: evidence of effectiveness and use.
Manchanda R; Chue P; Malla A; Tibbo P; Roy MA; Williams R; Iyer S; Lutgens D; Banks N
Can J Psychiatry; 2013 May; 58(5 Suppl 1):5S-13S. PubMed ID: 23945067
[TBL] [Abstract][Full Text] [Related]
20. [A history of antipsychotic long-acting injections in the treatment of schizophrenia].
Crocq MA
Encephale; 2015 Feb; 41(1):84-92. PubMed ID: 25598520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
